Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-24 @ 4:15 PM
NCT ID:
NCT03862066
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed histologically proven locoregional oral squamous cell carcinoma (OSCC) without evidence of distant metastases. OSCC includes the subsites of oral tongue, floor of mouth, gingiva, retromolar trigone and buccal mucosa OR
Recurrent or persistent histologically proven locoregional OSCC that was initially treated with surgery alone.
* must be eligible for surgical resection
* greater than 18 years of age
Exclusion Criteria:
* prior immunotherapy or treatment with another anti PD-1 agent besides nivolumab
* prior chemotherapy including cetuximab or radiation therapy
* concomitant malignancies except cutaneous squamous cell carcinoma or basal cell carcinoma
* unresectable primary tumor or regional disease or distant metastases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03862066
Study Brief:
Protocol Section:
NCT03862066